drugset / Trial / NCT01130298

An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier

NCT01130298

Phase 1 Completed 24 enrolled AbbVie
NaSingle-groupOpen-labelTreatment

Summary

Single-center, single dose, open-label study in healthy male and female volunteers to further characterize the transfer potential of Testosterone Gel 1.62% formulation.

Timeline

Start
2010-05
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 5 g Topical

Indications

No indication recorded.